Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01Jul 02, 2024
Clinical Trials
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
uniQure
PR-M09-19-NI-013Sep 06, 2019